Physician profile
Laith Mukdad
NPI 1568922508
$5,695.38
in general payments reported to CMS, 2019-2025
14 companies · $1,891 in 2025
The $1,891 reported for 2025 was more than what 89% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,678 · 2023: $122 · 2024: $2,005 · 2025: $1,891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,736 · Food and Beverage: $1,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,735.83 |
| Food and Beverage | $1,281.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $3,078.42 | 2024-2025 | Inspire |
| Stryker Corporation | $1,647.02 | 2022 | |
| Integra Lifesciences Corporation | $166.31 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Polynovo North America LLC | $146.97 | 2024 | Novosorb Btm |
| Abbvie INC. | $146.78 | 2024 | |
| Medtronic, INC. | $131.44 | 2024-2025 | Propel, Pteye Parathyroid Detection System |
| Regeneron Healthcare Solutions, INC. | $121.54 | 2023 | Dupixent |
| Genzyme Corporation | $69.02 | 2024-2025 | |
| Glaxosmithkline, LLC. | $45.63 | 2024-2025 | Nucala |
| Smith+Nephew, INC. | $36.85 | 2025 | Halo, Tula |
| Karl Storz Endoscopy-America | $31.38 | 2025 | Solo+ Ttd Handpiece |
| Biocryst US Sales Co., LLC | $28.88 | 2025 | Orladeyo |
| Novartis Pharmaceuticals Corporation | $24.42 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $20.72 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laith Mukdad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.